Rivera Díaz, Raquel Vanaclocha Sebastián, Francisco
Development of clinical prediction models for good or bad response to classic systemic drugs, anti-TNFs, and ustekinumab in psoriasis, based on the BIOBADADERM cohort. [artículo] - The Journal of dermatological treatment, 2016 - 27(3):203-9.
Formato Vancouver:
García Doval I, Pérez Zafrilla B, Ferrandiz C, Carretero G, Daudén E, de la Cueva P et al; BIOBADADERM Study Group. Development of clinical prediction models for good or bad response to classic systemic drugs, anti-TNFs, and ustekinumab in psoriasis, based on the BIOBADADERM cohort. J Dermatolog Treat. 2016;27(3):203-9.
PMID: 26367799
Development of clinical prediction models for good or bad response to classic systemic drugs, anti-TNFs, and ustekinumab in psoriasis, based on the BIOBADADERM cohort. [artículo] - The Journal of dermatological treatment, 2016 - 27(3):203-9.
Formato Vancouver:
García Doval I, Pérez Zafrilla B, Ferrandiz C, Carretero G, Daudén E, de la Cueva P et al; BIOBADADERM Study Group. Development of clinical prediction models for good or bad response to classic systemic drugs, anti-TNFs, and ustekinumab in psoriasis, based on the BIOBADADERM cohort. J Dermatolog Treat. 2016;27(3):203-9.
PMID: 26367799
